Study of Dysgeusia and Anosmia Frequency and Risk Factors in Pre-Elderly Post-Covid-19


  • Ari Tri Wanodyo Handayani Department of Public Dental Health Faculty of Dentistry Universitas Jember Jember
  • Zahreni Hamzah Department of Biomedical Dentistry Faculty of Dentistry Universitas Jember Jember
  • Dwi Prijatmoko Department of Orthodontic Faculty of Dentistry Universitas Jember Jember
  • Dyah Indartin Setyowati Department of Oral Medicine Faculty of Dentistry Universitas Jember Jember
  • Hosea Ferdinan Faculty of Dentistry Universitas Jember Jember



Aging, anosmia, Covid-19, dysgeusia, pre-elderly


Covid-19 is a respiratory obstruction caused by infection with SARS-CoV-2. The appearance of dysgeusia and anosmia can be a sign that someone has contracted this virus. This study aims to review the frequency and risk factors that cause dysgeusia and anosmia in pre-elderly post-Covid-19. This type of research is descriptive observational with a cross-sectional approach. In this study, only 5.15% of respondents experienced anosmia, 10.31% of dysgeusia alone, and 28.86% of dysgeusia accompanied by anosmia. Dysgeusia and anosmia can be found in every vaccination status. Respondents with ≥1 dominant comorbid were found in respondents who experienced dysgeusia accompanied by anosmia. Symptoms of fever, cough, rhinorrhea, and pneumonia are common in dysgeusia and anosmia disorders. The time of appearance of the disturbance ranges from 1-7 days, with the duration of the disruption 1-14 days. Symptoms of dysgeusia accompanied by anosmia in the pre-elderly post-Covid-19show a higher frequency than dysgeusia alone and anosmia alone. In pre-elderly, men were found to be more at risk than women. Several risk factors, including the aging process, co-morbidities, smoking habits, and vaccination status, support the emergence of these symptoms.


Download data is not yet available.


Martin CR, Susilo A, Wijaksono C, et al. Coronavirus Disease 2019: Tinjauan Literatur Terkini. Jurnal Penyakit Dalam Indonesia. 2020; 7(1): 45-67.

Hu B, Guo H, Zhou P, and Shi ZL. Characteristics of SARS-CoV-2 and COVID-19. Nature Reviews Microbiology. 2021; 19(1): 141-142.

World Health Organization. Naming the Coronavirus Disease (COVID-19) and the Virus that Causes It. (Online) 2020. diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(Covid-2019)-and-the-virus-that-causes-it [accessed 2021 October 31].

Lotfi M, Hamblim MR, and Rezaei N. COVID-19 Transmission, Prevention, and Potential Therapeutic Opportunities. Clinica Chimica Acta. 2020; 508: 254-266.

World Health Organization. Delta Variant. (Online) 2021. [accessed 2022 April 24].

Susanto AD, Rozaliyani A, Prasetyo B, et al. Epidemiological and Clinical Features of Covid-19 Patients at National Emergency Hospital Wisma Atlet Kemayoran, Jakarta, Indonesia. Kesmas. 2021; 16: 11–16.

Aditya, DMN. Anosmia pada COVID-19: Studi Neurobiologi. Jurnal Kesehatan dan Kedokteran. 2020; 2(1): 50-55.

Velmurugan and Subha M. Dysgeusia-A Review. Asian Journal of Pharmaceutical and Clinical Reaserch. 2013. 6(4): 16-18.

Mahmoud, MM., Abuohashish HM, Khairy DA, Bughsan AS, Khan AM, and Moothedath MM. Pathogenesis of Dysgeusia in COVID-19 Patients: A Scoping Review. European Review for Medical and Pharmacological Sciences. 2021; 25(2): 1114-1134.

Levinson R, Elbaz M, Ben-Ami R, et al. Time Course of Anosmia and Dysgeusia in Patients with Mild SARS-CoV-2 Infection. Infectious Diseases. 2020; 52(8): 600-602.

Patel A, Charani E, Ariyanayagam D, Abdulaal A, Denny SJ, Mughal N, and Moore LSP. New Onset Anosmia and Dysgeusia in Adult Patients Diagnoses with SARS-CoV-2 Infection. Clinical Microbiology and Infection. 2020; 26(9): 1236-1241.

Badan Pusat Statistik Kabupaten Jember. Distribusi Penduduk Menurut Kecamatan. (Online) 2020. [accessed 2022 June 8].

Verity, R., Okell LC, Dorigatti I, et al. Estimates of the Severity of Coronavirus Disease 2019: A Model-Based Analysis. The Lancet Infectious Disease. 2020; 20: 669 – 677.

Bilinska, K., Jakubowska P, Bartheld CSV, and Butowt R. Expression of the SARS-CoV-2 Entry Proteins, ACE-2 and TMPRSS2, in Cells of the Olfactory Epithelium: Identification of Cell Types and Trends with Age. American Chemical Society Chemical Neuroscience. 2020; 11(11): 1555-1562.

Peng, J., Sun J, Zhao J, Deng X, Guo F, and Chen L. Age and Gender Differences in ACE-2 and TMPRSS2 Expressions in Oral Epithelial Cells. Journal of Translational Medicine. 2021; 19(1): 1-11.

Theresa RM. Pengaruh Peningkatan Tekanan Darah terhadap Memori Jangka Pendek pada Pralansia di Kota Depok. Jurnal Kedokteran dan Kesehatan. 2020; 16(1): 1-5.

Syed Q, Hendler KT, and Koncilja K. The Impact of Aging and Medical Status on Dysgeusia. The American Journal of Medicine. 2016; 129(753): 1-6.

Hamzah Z, Indartin D, and Meilyawati Z. The Progressive Low Chronic Inflammation on Oral Tissue in Elderly. Proceeding ICHMS 2016. 2016: 177-179.

Eshraghi AA, Mirsaedi M, Davies C, Telischi FF, Chaudhari N, and Mittal R. Potential Mechanisms for COVID-19 Induced Anosmia and Dysgeusia. Frontiers in Physiology. 2020; 11: 1-4.

Mutiawati E, Fahriani M, Mamada SS, et al. Anosmia and Dysgeusia in SARS-Cov-2 Infection: Incidence and Effects on COVID-19 Severity and Mortality, and the Possible Pathobiology Mechanisms - A Systematic Review and Meta- Analysis. F1000 Research. 2021; 10: 1-28.

Park SS. Post-Glycosylation Modification of Sialic Acid and Its Role Virus Pathogenesis. Vaccines (Basel). 2019; 7(4): 1-18.

Lozada-Nur F, Chainani-Wu N, Fortuna G, and Sroussi H. Dysgeusia in COVID-19 Possible Mechanisms and Implications. Oral Surgery, Oral Medicine, Oral Pathology, and Oral Radiology. 2020; 130(3): 344-346.

Sepe S, Rossiello A, Cancila V, et al. DNA Damage Response at Telomers Boots the Transcription of SARS-CoV-2 receptor ACE-2 during Aging. EMBO Reports. 2022. 23(2): 1-14.

Demanelis K, Jasmine F, Chen LS, et al. Determinants of Telomere Length Across Human Tissues. Science. 2020; 369: 1-29.

Zalukhu ML, Pyma AR, and Pinzon RT. Proses Menua, Stress, Oksidatif, dan Peran Anti Oksidan. Cermin Dunia Kedokteran. 2016; 43(10): 733–736.

Schubert, CR, Cruickshanks KJ, Fischer ME, et al. Olfactory Impairment in an Adult Population: The Beaver Dam Offspring Study. Chemical Senses. 2012. 37(4): 325–334.

Guan WJ, Liang WH, Zhao Y, et al. Comorbidity and Its Impact on 1590 Patients with COVID-19 in China: A Nationwide Analysis. Eur Respir J. 2020; 55(5): 1-14.

Kementerian Kesehatan Republik Indonesia. Hasil Utama Riskesdas 2018. Jakarta: Kementrian Kesehatan RI Badan Penelitian dan Pengembangan Kesehatan; 2018.

Glennon SG, Huedo-Medina T, Rawal S, Hoffman HJ, Litt MD, and Duffy VB. Chronic Cigarette Smoking Associates Directly and Indirectly with Self-Reported Olfactory Alterations: Analysis of the 2011-2014 National Health and Nutrition Examination Survey. Nicotine & Tobacco Research. 2019; 21(6): 818–827.

Li YC, Bai WZ, and Hashikawa T. The Neuroinvasive Potential of SARS-Cov2 May Plays a Role in the Respiratory Failure of COVID-19 Patients. Journal of Medical Virology. 2020; 92(6): 552–555.

Okui T, Matsuda Y, Karino M, Hideshima K, and Kanno T. Oral Mucosa Could Be an Infectious Target of Sars-Cov-2. Healthcare (Basel). 2021; 9(8): 1-8.

Ueha R, Ueha S, Kondo K, Nishijima H, and Yamasoba T. Effects of Cigarette Smoke on the Nasal Respiratory and Olfactory Mucosa in Allergic Rhinitis Mice. Frontiers Neuroscience. 2020; 14: 1-14.

Lechien JR, Chiesa-Estomba CM, de Siati DR, et al. Olfactory and Gustatory Dysfunctions as a Clinical Presentation of Mild-To-Moderate Forms of the Coronavirus Disease (COVID-19): A Multicenter European Study. European Archives of Oto-Rhino-Laryngology. 2020; 277(8): 2251–2261.

Sadat MM, Alaee A, and Alirezaezi A. Management of Xerostomia in COVID-19 Patients: A Review Article. Journal of Research in Dental Sciences. 2021; 18(3): 228–240.



2023-08-31 — Updated on 2023-08-31



Research Article